2024-12-28 05:37:07
CHMP Adopts Positive Opinion for BAVENCIO® (avelumab) Plus Axitinib for First-Line Treatment of Patients with Advanced Renal Cell Carcinoma
Corporate/ 2023-07-23
CHMP Adopts Positive Opinion for BAVENCI...

Not intended for US,Canada and UK-based media Opinion based on Phase III data showing combination lowered risk of disease progression or dea...

2019 CSCO | CStone announces preliminary results from Phase I trial of CS1002 demonstrating characteristics comparable to ipilimumab
Corporate/ 2023-07-23
2019 CSCO | CStone announces preliminary...

SUZHOU,China,Sept. 22,2019--CStone Pharmaceuticals ("CStone" or the "Company",HKEX: 2616) today announced preliminary re...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release